OREGON PUBLIC EMPLOYEES RETIREMENT FUND - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 177 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$133,044
-47.9%
6,217
-1.6%
0.00%
-33.3%
Q1 2023$255,459
-15.2%
6,317
-2.4%
0.00%
-25.0%
Q4 2022$301,077
-10.1%
6,472
+0.2%
0.00%
-20.0%
Q3 2022$335,000
+17.1%
6,458
+6.7%
0.01%
+25.0%
Q2 2022$286,000
-40.3%
6,051
-10.0%
0.00%
-20.0%
Q1 2022$479,000
-7.5%
6,727
-2.9%
0.01%
-16.7%
Q4 2021$518,000
+27.0%
6,927
-3.6%
0.01%
+20.0%
Q3 2021$408,000
+29.1%
7,1820.0%0.01%
+25.0%
Q2 2021$316,000
-10.7%
7,1820.0%0.00%0.0%
Q1 2021$354,000
+18.8%
7,182
+1.4%
0.00%0.0%
Q4 2020$298,000
+0.3%
7,082
+9.1%
0.00%0.0%
Q3 2020$297,000
-8.9%
6,4940.0%0.00%
-20.0%
Q2 2020$326,000
-2.4%
6,4940.0%0.01%
-16.7%
Q1 2020$334,000
-16.7%
6,4940.0%0.01%0.0%
Q4 2019$401,000
+2.8%
6,4940.0%0.01%
+20.0%
Q3 2019$390,000
-25.4%
6,494
+4.8%
0.01%
-28.6%
Q2 2019$523,000
-10.1%
6,194
+1.6%
0.01%
-12.5%
Q1 2019$582,000
+37.3%
6,094
+1.8%
0.01%
+14.3%
Q4 2018$424,0005,9840.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,055,719$35,367,00012.68%
GREAT POINT PARTNERS LLC 828,253$27,746,0005.70%
McClain Value Management LLC 116,153$3,891,0004.80%
Stonepine Capital Management, LLC 231,913$7,769,0004.63%
ARMISTICE CAPITAL, LLC 228,000$7,638,0001.81%
Opaleye Management Inc. 90,000$3,015,0001.78%
Matarin Capital Management, LLC 257,268$8,618,478,0000.97%
HAYS ADVISORY LLC 116,939$3,917,0000.87%
Granahan Investment Management 496,025$16,617,0000.57%
AlphaMark Advisors, LLC 33,000$1,106,0000.57%
View complete list of ENANTA PHARMACEUTICALS INC shareholders